HITI trades 20.5% below Wall Street's consensus target of $2.70.
Last 12 months price action with 12-month analyst target path
The base valuation assumes HITI achieves its forward estimates and maintains a stable P/E multiple of 60.7x. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 29, 2026, High Tide Inc. (HITI) has a Wall Street consensus price target of $2.70, based on estimates from 4 covering analysts. With the stock currently trading at $2.24, this represents a potential upside of +20.5%. The company has a market capitalization of $197M.
Analyst price targets range from a low of $2.70 to a high of $2.70, representing a 0% spread in expectations. The median target of $2.70 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, HITI trades at a trailing P/E of -5.1x and forward P/E of 60.7x. Analysts expect EPS to grow +107.4% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
FLGCFlora Growth Corp. | $88M | $7.21 | — | — | — | — | — |
IIPRInnovative Industrial Properties, Inc. | $1.8B | $62.93 | $84.67 | +34.5% | Hold | 14.7x | 11 |
MAPSWM Technology, Inc. | $67M | $0.39 | — | — | — | — | — |
SGBXSafe & Green Holdings Corp. | $32963 | $0.96 | — | — | — | — | — |
TLRYTilray Brands, Inc. | $541M | $4.64 | $10.00 | +115.5% | Hold | — | 20 |
CGCCanopy Growth Corporation | $364M | $0.95 | $14.47 | +1429.8% | Hold | — | 27 |
ACBAurora Cannabis Inc. | $175M | $2.83 | $5.92 | +109.2% | Hold | — | 14 |
SNDLSNDL Inc. | $360M | $1.39 | $3.95 | +184.2% | Hold | — | 6 |
OGIOrganigram Global Inc. | $145M | $1.03 | — | — | Buy | 12.0x | 5 |
CRONCronos Group Inc. | $1.0B | $2.81 | $2.30 | -18.1% | Hold | 32.1x | 15 |
Quick answers to the most common questions about buying HITI stock.
The consensus Wall Street price target for HITI is $2.7, representing 20.5% upside from the current price of $2.24. With 4 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
HITI has a consensus rating of "Buy" based on 4 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $2.7 implies 20.5% upside from current levels.
At a forward P/E of 60.7046x, HITI trades at a premium valuation. The consensus price target of $2.7 (20.5% upside) suggests analysts still see growth justifying the multiple.
The most bullish Wall Street analyst has a price target of $2.7 for HITI, while the most conservative target is $2.7. The consensus of $2.7 represents the median expectation. These targets typically reflect 12-month expectations.
HITI is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month HITI stock forecast based on 4 Wall Street analysts shows a consensus price target of $2.7, with estimates ranging from $2.7 (bear case) to $2.7 (bull case). The median consensus rating is "Buy".
HITI trades at a forward P/E ratio of 60.7x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on HITI, with a "Buy" consensus rating and $2.7 price target (20.5% upside). 3 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
HITI analyst price targets range from $2.7 to $2.7, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $2.7 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.